Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Persimmon Sees Rise In Half Year Earnings

Tue, 21st Aug 2018 07:38

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday with US-China trade talks in focus, as Persimmon reported an increased profit for the first half. IG futures indicate the FTSE 100 index is to open down 18.36 points at 7,572.90. The blue chip index closed up 0.4% at 7,591.26 on Monday. In early UK corporate news, miner BHP Billiton paid out to shareholders above its policy level, with annual profit rising though short of consensus.For the 12 months to June, BHP is paying a "record" final dividend of 63 US cents a share, 17 cents above its policy of paying 50% of underlying attributable profit.The total dividend for BHP's financial year was 118 cents, far higher than the 83 cents paid out a year earlier and above analyst consensus of a 116 cents return.BHP's pretax profit rose to USD14.75 billion from USD11.14 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation was up 20% to USD23.18 billion.Housebuilder Persimmon said it saw a strong first half of 2018 reflecting its commitment to delivery of high quality growth.For the half year to the end of June, revenue rose 5% to GBP1.84 billion from GBP1.75 billion last year and pretax profit was up 13% to GBP516.3 million from GBP457.4 million last year. New home sales increased 4% to 8,072 from 7,794 last year - with an additional 278 new homes delivered in the period.Persimmon said it returned surplus capital to shareholders of 125 pence per share in March 2018, in addition to the payment of 110 pence per share paid in July. The company added that it remained committed to return surplus capital of at least 235 pence per share for the next two years ending 2020, and 110 pence per share in 2021."The group has a robust platform to continue to deliver successful outcomes based on its high quality land bank, strong forward sales, excellent financial position, and experienced management team. We believe we are well positioned to deliver further high quality, sustainable growth," said Chief Executive Jeff Fairburn.Anglo-Swedish drugmaker AstraZeneca said its non-small-cell lung carcinoma drug Tagrisso has been approved in Japan as a first line treatment. "Tagrisso is already approved in Japan for the treatment of patients with EGFR T790M mutation-positive inoperable or recurrent NSCLC that is resistant to existing 1st-line EGFR-inhibitor medicines. Today's approval moves the use of Tagrisso to the 1st-line setting, replacing older medicines which, given the high prevalence of the EGFR mutation in Japan, offers an important new treatment option for these patients," said Dave Fredrickson, head of its Oncology unit. Gold miner Polymetal International reported strong earnings on the back of solid operational delivery in the first half of the year.For the half year to the end of June, revenue was up 16% to USD789.0 million from USD683.0 million last year and net earnings were up 46% to USD175.0 million from USD120.0 million the year before. Gold sales in the first half were up 17% at 445,000 ounces, although silver was down 2% at 12.1 million ounces.Polymetal declared an interim dividend of 0.17 cents, up 21% from 0.14 cents paid last year. "We expect stronger production and free cash flow generation for the second half and remain focused on steadily progressing our further growth pipeline, including full ramp-up of Kyzyl, while generating meaningful dividends to our shareholders," said Chief Executive Vitaly Nesis.The Japanese Nikkei 225 index closed up 0.1%. In China, the Shanghai Composite is up 1.4%, while the Hang Seng index in Hong Kong is up 0.6%.Asian stock markets are higher following the modest gains overnight on Wall Street amid optimism over US-China trade talks. The dollar declined after a report from Reuters said that US President Donald Trump accused China, as well as Europe, of manipulating their currencies and also said he was "not thrilled" with Federal Reserve Chair Jerome Powell for raising interest rates.In the US on Monday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.4%, S&P 500 up 0.2% and Nasdaq Composite up 0.1%. The pound was up against the dollar quoted at USD1.2843 compared to USD1.2761 on Monday.Still to come in the economic calendar in Europe is UK public sector borrowing figures at 0930 BST.
More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.